Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
4SC AG ( (DE:VSC) ) has shared an announcement.
4SC AG has announced a strategic financial restructuring plan involving a capital reduction to zero followed by a cash capital increase, which will result in the delisting of the company from the Frankfurt Stock Exchange. This move is aimed at covering losses and exploring strategic realignment opportunities, potentially utilizing existing tax loss carryforwards. Major shareholders have committed to the full subscription of the new shares, and the plan awaits approval at the upcoming Annual General Meeting. The capital measures are contingent on a binding ruling from tax authorities to ensure tax loss carryforwards remain unaffected.
More about 4SC AG
4SC AG is a company based in Planegg-Martinsried, Germany, previously involved in the development and commercialization of drug candidates. The company was listed on the Frankfurt Stock Exchange and focused on the pharmaceutical industry, although it has recently discontinued its last remaining drug candidate, Resminostat.
Average Trading Volume: 5,344
Technical Sentiment Signal: Sell
Current Market Cap: €10.3M
Find detailed analytics on VSC stock on TipRanks’ Stock Analysis page.